342 related articles for article (PubMed ID: 27444575)
21. Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives.
Knudsen K; Krogh K; Østergaard K; Borghammer P
Mov Disord; 2017 Jan; 32(1):94-105. PubMed ID: 27873359
[TBL] [Abstract][Full Text] [Related]
22. [Pathophysiological process underlying Parkinson's disease: motor & non-motor symptoms].
Takeda A; Baba T; Kikuchi A; Sugeno N; Hasegawa T; Itoyama Y; Ishioka T; Hirayama K; Mori E
Rinsho Shinkeigaku; 2009 Nov; 49(11):888-9. PubMed ID: 20030239
[TBL] [Abstract][Full Text] [Related]
23. Colonic neuropathology is not associated with autonomic dysfunction in Parkinson's disease.
Leclair-Visonneau L; Clairembault T; Volteau C; Chapelet G; Le Dily S; Vavasseur F; Coron E; Préterre C; Neunlist M; Péréon Y; Derkinderen P
Parkinsonism Relat Disord; 2019 Apr; 61():224-227. PubMed ID: 30262379
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease.
Yan F; Chen Y; Li M; Wang Y; Zhang W; Chen X; Ye Q
Medicine (Baltimore); 2018 Jul; 97(28):e11337. PubMed ID: 29995769
[TBL] [Abstract][Full Text] [Related]
25. Lewy pathological study on α-synuclein in gastrointestinal tissues of prodromal Parkinson's disease.
Lu QB; Zhu ZF; Zhang HP; Luo WF
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1514-1521. PubMed ID: 28429355
[TBL] [Abstract][Full Text] [Related]
26. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.
Schneider SA; Boettner M; Alexoudi A; Zorenkov D; Deuschl G; Wedel T
Eur J Neurol; 2016 Feb; 23(2):247-61. PubMed ID: 26100920
[TBL] [Abstract][Full Text] [Related]
27. The relationship between inflammatory bowel disease and Parkinson's disease: true or fiction?
Carmona-Abellan M; Rodríguez-Lago I; Cabriada JL; Gómez-Esteban JC
Scand J Gastroenterol; 2019 Jul; 54(7):886-889. PubMed ID: 31314610
[TBL] [Abstract][Full Text] [Related]
28. Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker.
Chung SJ; Kim J; Lee HJ; Ryu HS; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Lee JY; Hong SM; Myung SJ
Mov Disord; 2016 Feb; 31(2):241-9. PubMed ID: 26686342
[TBL] [Abstract][Full Text] [Related]
29. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
[TBL] [Abstract][Full Text] [Related]
30. Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease.
Fricova D; Harsanyiova J; Kralova Trancikova A
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212934
[TBL] [Abstract][Full Text] [Related]
31. Constipation in Parkinson's Disease.
Quigley EMM
Semin Neurol; 2023 Aug; 43(4):562-571. PubMed ID: 37579786
[TBL] [Abstract][Full Text] [Related]
32. Life style risks of Parkinson's disease: association between decreased water intake and constipation.
Ueki A; Otsuka M
J Neurol; 2004 Oct; 251 Suppl 7():vII18-23. PubMed ID: 15505750
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers of Nonmotor Symptoms in Parkinson's Disease.
Konno T; Al-Shaikh RH; Deutschländer AB; Uitti RJ
Int Rev Neurobiol; 2017; 133():259-289. PubMed ID: 28802922
[TBL] [Abstract][Full Text] [Related]
34. Management of Gastrointestinal Symptoms in Parkinson's Disease: A Comprehensive Review of Clinical Presentation, Workup, and Treatment.
Pasricha TS; Guerrero-Lopez IL; Kuo B
J Clin Gastroenterol; 2024 Mar; 58(3):211-220. PubMed ID: 38260966
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms.
Cersosimo MG; Raina GB; Pecci C; Pellene A; Calandra CR; Gutiérrez C; Micheli FE; Benarroch EE
J Neurol; 2013 May; 260(5):1332-8. PubMed ID: 23263478
[TBL] [Abstract][Full Text] [Related]
36. The effect of electroacupuncture at ST25 on Parkinson's disease constipation through regulation of autophagy in the enteric nervous system.
Song LZ; Xu N; Yu Z; Yang H; Xu CC; Qiu Z; Dai JW; Xu B; Hu XM
Anat Rec (Hoboken); 2023 Dec; 306(12):3214-3228. PubMed ID: 36655864
[TBL] [Abstract][Full Text] [Related]
37. More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.
Mertsalmi TH; Aho VTE; Pereira PAB; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
Eur J Neurol; 2017 Nov; 24(11):1375-1383. PubMed ID: 28891262
[TBL] [Abstract][Full Text] [Related]
38. [Autonomic nervous system as a source of biomarkers in Parkinson's disease].
Pouclet H; Lebouvier T; Flamant M; Coron E; Neunlist M; Derkinderen P; Rouaud T
Presse Med; 2012 Jul; 41(7-8):695-701. PubMed ID: 22284542
[TBL] [Abstract][Full Text] [Related]
39. BDNF and Netrin-1 repression by C/EBPβ in the gut triggers Parkinson's disease pathologies, associated with constipation and motor dysfunctions.
Ahn EH; Kang SS; Liu X; Cao X; Choi SY; Musazzi L; Mehlen P; Ye K
Prog Neurobiol; 2021 Mar; 198():101905. PubMed ID: 32911010
[TBL] [Abstract][Full Text] [Related]
40. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease.
Anis E; Xie A; Brundin L; Brundin P
Trends Endocrinol Metab; 2022 Feb; 33(2):147-157. PubMed ID: 34949514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
